Growth Metrics

Cytek Biosciences (CTKB) Preferred Dividend Payments (2020 - 2021)

Cytek Biosciences filings provide 2 years of Preferred Dividend Payments readings, the most recent being -$1.2 million for Q4 2021.

  • On a quarterly basis, Preferred Dividend Payments fell 104.35% to -$1.2 million in Q4 2021 year-over-year; TTM through Dec 2022 was -$1.2 million, a 103.98% decrease, with the full-year FY2021 number at $3.0 million, down 81.47% from a year prior.
  • Preferred Dividend Payments hit -$1.2 million in Q4 2021 for Cytek Biosciences, down from $1.1 million in the prior quarter.
  • In the past five years, Preferred Dividend Payments ranged from a high of $27.4 million in Q4 2020 to a low of -$6.2 million in Q2 2020.